SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-326654
Filing Date
2019-12-31
Accepted
2019-12-31 16:49:14
Documents
5
Effectiveness Date
2019-12-31

Document Format Files

Seq Description Document Type Size
1 S-8 d858692ds8.htm S-8 69666
2 EX-5.1 d858692dex51.htm EX-5.1 5469
3 EX-23.1 d858692dex231.htm EX-23.1 1652
4 GRAPHIC g858692g29y58.jpg GRAPHIC 3087
5 GRAPHIC g858692g50c54.jpg GRAPHIC 2527
  Complete submission text file 0001193125-19-326654.txt   85834
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-235765 | Film No.: 191319893
SIC: 2834 Pharmaceutical Preparations